111 related articles for article (PubMed ID: 34093635)
1. Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network.
Pu Z; Zhu Y; Wang X; Zhong Y; Peng F; Zhang Y
Front Genet; 2021; 12():591623. PubMed ID: 34093635
[TBL] [Abstract][Full Text] [Related]
2. Construction of a circRNA-miRNA-mRNA Network Related to Macrophage Infiltration in Hepatocellular Carcinoma.
Zhou P; Zheng G; Li Y; Wu D; Chen Y
Front Genet; 2020; 11():1026. PubMed ID: 33101367
[TBL] [Abstract][Full Text] [Related]
3. Prognostic model and ceRNA network of m7G- and radiosensitivity-related genes in hepatocellular carcinoma.
Liu M; Zhu M; Huang Y; Wu J; Peng Z; Liang Y
Heliyon; 2024 May; 10(9):e29925. PubMed ID: 38707306
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of RACGAP1 is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma.
Zhou Y; Zheng S; Guo Q; Wei N; Xiao Z; Song Y
Transl Cancer Res; 2024 Feb; 13(2):847-863. PubMed ID: 38482449
[TBL] [Abstract][Full Text] [Related]
5. Construction of CDKN2A-related competitive endogenous RNA network and identification of GAS5 as a prognostic indicator for hepatocellular carcinoma.
Pan Y; Zhang YR; Wang LY; Wu LN; Ma YQ; Fang Z; Li SB
World J Gastrointest Oncol; 2024 Apr; 16(4):1514-1531. PubMed ID: 38660664
[TBL] [Abstract][Full Text] [Related]
6. Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicine.
Guo S; Xing N; Du Q; Luo B; Wang S
Front Pharmacol; 2023; 14():1325992. PubMed ID: 38283837
[No Abstract] [Full Text] [Related]
7. Correction to: Construction of a New Immune-Related Competing Endogenous RNA Network with Prognostic Value in Lung Adenocarcinoma.
Liu L; Li J; Fan C; Wen M; Li C; Sun W; Wang W
Mol Biotechnol; 2024 Jun; 66(6):1496. PubMed ID: 37368193
[No Abstract] [Full Text] [Related]
8. ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.
Lin X; Wang ZY; Xue G; Qin XJ; Wu JF; Zhang G
J Cancer; 2021; 12(13):3997-4010. PubMed ID: 34093805
[No Abstract] [Full Text] [Related]
9. Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma.
Zeng F; Zhang Y; Han X; Zeng M; Gao Y; Weng J
Comput Struct Biotechnol J; 2021; 19():2775-2789. PubMed ID: 34093992
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis.
Tao H; Li J; Liu J; Yuan T; Zhang E; Liang H; Huang Z
J Cancer; 2021; 12(13):3754-3768. PubMed ID: 34093785
[No Abstract] [Full Text] [Related]
11. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma.
Liu XS; Gao Y; Wu LB; Wan HB; Yan P; Jin Y; Guo SB; Wang YL; Chen XQ; Zhou LM; Yang JW; Kui XY; Liu XY; Pei ZJ
Front Oncol; 2021; 11():665388. PubMed ID: 34123828
[TBL] [Abstract][Full Text] [Related]
13. SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
Jiang P; Cao Y; Gao F; Sun W; Liu J; Ma Z; Xie M; Fu S
BMC Cancer; 2021 Jun; 21(1):694. PubMed ID: 34116656
[TBL] [Abstract][Full Text] [Related]
14. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Xu H; Xiong C; Chen Y; Zhang C; Bai D
Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
[TBL] [Abstract][Full Text] [Related]
15. KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer.
Qiu MJ; Wang QS; Li QT; Zhu LS; Li YN; Yang SL; Xiong ZF
Front Mol Biosci; 2021; 8():559800. PubMed ID: 34109209
[No Abstract] [Full Text] [Related]
16. SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Zhao J; Cao H; Zhang W; Fan Y; Shi S; Wang R
BMC Cancer; 2021 Jun; 21(1):675. PubMed ID: 34098886
[TBL] [Abstract][Full Text] [Related]
17.
Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
Front Oncol; 2021; 11():658547. PubMed ID: 34094951
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
20. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
Lin G; Wang H; Wu Y; Wang K; Li G
Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
